ACELYRIN, INC. - Common Stock (NQ:SLRN)

2.270 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 20, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ACELYRIN, INC. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Lowey Dannenberg Notifies ACELYRIN, Inc. (“Acelyrin” or the “Company”) (NASDAQ: SLRN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm

November 28, 2023

From Lowey Dannenberg, P.C.

Via GlobeNewswire

Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

November 28, 2023

Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering.

Via Benzinga

Why Is Inflammation Disease Focused Acelyrin Stock Trading Lower Today? ↗

November 28, 2023

Acelyrin Inc (NASDAQ: SLRN) updated its izokibep clinical development program, including its ongoing global Phase 2b/3 trial for izokibep in

Via Benzinga

What 5 Analyst Ratings Have To Say About Acelyrin ↗

November 28, 2023

Via Benzinga

NASDAQ:SLRN Investor Notice: Investigation over Potential Wrongdoing at Acelyrin, Inc. ↗

October 31, 2023

San Diego, CA -- (SBWIRE) -- 10/31/2023 -- Certain directors of Acelyrin, Inc. are under investigation over potential breaches of fiduciary duties.

Via SBWire

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ACELYRIN, Inc. (SLRN)

November 28, 2023

From Law Offices of Howard G. Smith

Via Business Wire

ROSEN, LEADING INVESTOR COUNSEL, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN

November 27, 2023

From The Rosen Law Firm PA

Via GlobeNewswire

ACELYRIN, INC. Provides Update on Izokibep Clinical Development Program

November 27, 2023

From ACELYRIN, INC.

Via GlobeNewswire

November 27, 2023

From Lowey Dannenberg, P.C.

Via GlobeNewswire

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of ACELYRIN, Inc. (SLRN) Investors

November 27, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

ACELYRIN ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Acelyrin To Contact Him Directly To Discuss Their Options

November 26, 2023

From Faruqi & Faruqi LLP

Via GlobeNewswire

ACELYRIN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Acelyrin, Inc. and Encourages Investors to Contact the Firm

November 25, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, NATIONAL TRIAL LAWYERS, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SLRN

November 25, 2023

WHY: NEW YORK, NY - (NewMediaWire) - November 25, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC. (NYSE: SLRN) between May 4, 2023 and...

Via NewMediaWire

Topics Lawsuit

SLRN NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN

November 24, 2023

From The Rosen Law Firm PA

Via GlobeNewswire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of ACELYRIN, Inc. (SLRN) Investors

November 22, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of ACELYRIN, Inc. (SLRN) Investors

November 22, 2023

From Law Offices of Howard G. Smith

Via Business Wire

ROSEN, LEADING INVESTOR COUNSEL, Encourages ACELYRIN, INC. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SLRN

November 21, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

ACELYRIN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Acelyrin, Inc. and Encourages Investors to Contact the Firm

November 20, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SLRN

November 19, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

ROSEN, A LEADING LAW FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN

November 18, 2023

From The Rosen Law Firm PA

Via GlobeNewswire

Acelyrin, Inc. (SLRN) Investor Notice: Robbins LLP Reminds Investors of Class Action Filed Against Acelyrin, Inc.

November 17, 2023

From Robbins LLP

Via Business Wire

EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN

November 16, 2023

From The Rosen Law Firm, P.A.

Via Business Wire

SLRN INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that ACELYRIN, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

November 16, 2023

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

ACELYRIN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Acelyrin, Inc. and Encourages Investors to Contact the Firm

November 15, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

Acelyrin (SLRN) Q3 2023 Earnings Call Transcript ↗

November 07, 2023

SLRN earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

ACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights

November 07, 2023

From ACELYRIN, INC.

Via GlobeNewswire

ACELYRIN, INC. Appoints Patricia Turney as Chief Technical Operations Officer

November 06, 2023

From Acelyrin, Inc.

Via GlobeNewswire

Earnings Scheduled For November 7, 2023 ↗

November 07, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

Via Benzinga

ACELYRIN, INC. to Report Third Quarter 2023 Financial Results and Corporate Update on November 7, 2023

October 31, 2023

From Acelyrin, Inc.

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Acelyrin, and Clorox and Encourages Investors to Contact the Firm

October 18, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.